Discovering the functions of cytochrome P450 in drug metabolism: The role of Alfred Hildebrandt

Drug Metabolism Reviews

Volumn 31, Issue 2, 1999, Pages 317-331

  Estabrook, Ronald W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Action spectrum; Carbon monoxide inhibition; Drag metabolism; Hydroxylation reactions; Metyrapone; Oxy P450; Steroid hormone synthesis; Substrate binding

Indexed keywords

CARBON MONOXIDE; CYTOCHROME P450; STEROID HORMONE;

CONFERENCE PAPER; DRUG HYDROXYLATION; DRUG METABOLISM; DRUG RESEARCH; ENZYME ACTIVITY; FAMILY; LIVER METABOLISM; LIVER MICROSOME; PUBLICATION; RESPIRATORY CHAIN; STEROIDOGENESIS; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GERMANY; HISTORY, 20TH CENTURY; HUMANS; PHARMACEUTICAL PREPARATIONS; STEROIDS; SUBSTRATE SPECIFICITY; UNITED STATES;

EID: 0032900597     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-100101920     Document Type: Conference Paper

References (47)

1. R. W. Estabrook, D. Y. Cooper, and O. Rosenthal, The light-reversible carbon monoxide inhibition of the steroid C-21 hydroxylation system of the adrenal cortex, Biochem. Z., 338, 741-755 (1963).
2. D. Y. Cooper, S. Levin, S. Narasimhulu, O. Rosenthal, and R. W. Estabrook, Photochemical Action Spectrum of the terminal oxidase of mixed function oxidase systems, Science, 147, 400-402 (1965).
3. C. P. Sherwin, The fate of foreign compounds in the animal body, Physiol. Rev., 2, 238-276 (1922).
4. R. T. Williams, Detoxication Mechanisms, Chapman & Hall, London, 1947.
5. J. A. Miller, and E. C. Miller, The carcinogenic aminoazo dyes, Adv. Cancer Res., 1, 340-396 (1953).
6. J. Axelrod, The enzymatic deamination of amphetamine (Benzedrine), J. Biol. Chem., 214, 753-763 (1955).
7. B. B. Brodie, J. R. Gillette, and B. N. LaDu, Enzymatic metabolism of drugs and other foreign compounds, Annu. Rev. Biochem., 27, 427-454 (1958).
8. G. C. Mueller and J. A. Miller, The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates, J. Biol. Chem., 176, 535-544 (1948).
9. J. Axelrod, The enzymatic demethylation of ephedrine, J. Pham. Exp. Therap., 114, 430-438 (1955).
10. K. J. Ryan, and L. L. Engel, Hydroxylation of steroids at carbon 21, J. Biol. Chem., 225, 103-114 (1957).
11. M. Klingenberg, Pigments of rat liver microsomes, Arch. Biochem. Biophys., 75, 376-386 (1958).
12. T. Omura and R. Sato, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature, J. Biol. Chem., 239, 2370-2378 (1964).
13. T. Omura and R. Sato, The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties, J. Biol. Chem., 239, 2379-2385 (1964).
14. B. Chance, Techniques for the assay of the respiratory enzymes, in Methods Enzymol., 4, 273-328 (1957).
15. B. Chance and G. R. Williams, A method for the localization of sites for oxidative phosphorylation, Nature, 176, 250-254 (1955).
16. C. F. Strittmatter and E. G. Ball, A hemochromogen component of liver microsomes, Proc. Natl. Acad. Sci. USA, 38, 19-25 (1952).
17. R. Sato, Opening remarks to the Yamada Conference XVII, in Cytochrome P-450: New Trends (R. Sato, T. Omura, Y. Imai, and Y. Fujii Kuriyama, eds.), Yamada Science Foundation, Yamada 1987, pp. 13-17.
18. R. W. Estabrook and S. P. Nissley, Observations on mitochondrial pyridine nucleotides during oxidative phosphorylation, in Funktionelle und Morphologische Organisation der Zelle, Wissenschaftliche Konferenz der Gessellschaft Deutscher Naturforscher und Aerzte in Rottach-Egern, Springer-Verlag, Heidelberg, 1963, pp. 119-136.
19. P. K. Maitra and R. W. Estabrook, A fluorometric method for the enzymic determination of glycolytic intermediates, Anal. Biochem., 7, 472-484 (1964).
20. M. J. Spiro and E. G. Ball, Studies on the respiratory enzymes of the adrenal gland. II The cortex., J. Biol. Chem., 236, 231-235 (1961).
21. D. Y. Cooper, R. W. Estabrook, and O. Rosenthal, On the cytochromes in microsomes from cortex and medulla of steer adrenals, Fed. Proc., 22, 587 (1963).
22. H. S. Mason, Mechanisms of oxygen metabolism, in Advances in Enzymology (F. F. Nord, ed.), Academic Press, New York, 1957, pp. 79-234.
23. O. Hayaishi, History and scope, in Oxygenases (O. Hayaishi, ed), Academic Press, New York, 1962, pp. 1-29.
24. D. Y. Cooper, R. W. Estabrook, and O. Rosenthal, The stoichiometry of C21 hydroxylation of steroids by adrenocortical microsomes, J. Biol. Chem., 238, 1320-1323 (1963).
25. O. Warburg, Heavy Metal Prosthetic Groups and Enzyme Action, Chapter XI, Clarendon Press, Oxford, 1949, Chap. XI.
26. D. Y. Cooper, Discovery of the function of the heme protein P-450: A systematic approach to scientific research, Life Sci., 13, 1151-1161 (1973).
27. R. W. Estabrook, Cytochrome P450: From a single protein to a family of proteins - with some personal reflections, in Cytochromes P450: Metabolic and Toxicological Aspects (C. Ionnides, ed.), CRC Press, Boca Raton, FL, 1995.
28. H. Remmer and H. J. Merker, The effect of drugs on the formation of smooth endoplasmic reticulum and drug-metabolizing enzymes, Ann. NY Acad. Sci., 123, 79-97 (1965).
29. S. Orrenius, G. Dallner, and L. Ernster, Inhibition of the TPNH-linked lipid peroxidation of liver microsomes by drugs undergoing oxidative demethylation, Biochem. Biophys. Res. Commun., 14, 329-334 (1964).
30. S. Narasimhulu, D. Y. Cooper, and O. Rosenthal, Spectrophotometric properties of a Triton-clarified steroid 21-hydroxylase system of adrenocortical microsomes, Life Sci., 4, 2101-2107 (1965).
31. H. Remmer, J. Schenkman, R. W. Estabrook, H. Sasame, J. Gillette, S. Narasimhulu, O. Y. Cooper, and O. Rosenthal, Drug interaction with hepatic microsomal cytochrome, Mol. Pharmacol., 2, 187-190 (1966).
32. J. B. Schenkman, H. Remmer, and R. W. Estabrook, Spectral studies of drug interactions with hepatic microsomal cytochrome, Mol. Pharmacol., 3, 113-123 (1967).
33. T. Omura, E. Sanders, R. W. Estabrook, D. Y. Cooper, and O. Rosenthal, Isolation from adrenal cortex of a non-heme iron protein and a flavoprotein functional as a reduced triphosphopyridine nucleotide-cytochrome P-450 reductase, Arch. Biochem. Biophys., 117, 660-673 (1966).
34. R. W. Estabrook, A. G. Hildebrandt, and V. Ullrich, Oxygen interaction with cytochrome P-450, Hoppe-Seyler's Z. Physiol. Chem., 349, 1605-1608 (1968).
35. R. Kahl, H. G. Jonen, and G. F. Kahl, Effect of phenobarbital and 3-methylcholanthrene administration in vivo and isooctane extraction in vitro on metyrapone binding to reduced cytochrome P-450, Biochem. Pharmacol., 23, 2305-2311 (1974).
36. N. E. Sladek and G. J. Mannering, Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats, Biochem. Biophys. Res. Commun., 24, 668-674 (1966).
37. A. Hildebrandt, H. Remmer, and R. W. Estabrook, Cytochrome P-450 of liver microsomes - one pigment or many, Biochem. Biophys. Res. Commun., 30, 607-612 (1966).
38. A. G. Hildebrandt and R. W. Estabrook, Spectrophotometric studies of cytochrome P-450 of liver microsomes after induction with phenobarbital and 3-methylcholanthrene, in Microsomes and Drug Oxidations (J. Gillette, A. H. Conney, G. J. Cosmides, R. W. Estabrook, J. R. Fouts, and G. J. Mannering, eds.), Academic Press, New York, 1969, pp. 331-349.
39. 5 reduction, Arch. Biochem. Biophys., 142, 37-45 (1968).
40. 5 in hepatic microsomal mixed-function oxidation reactions, Arch. Biochem. Biophys., 143, 66-79 (1971).
41. Y. Ishimura, V. Ullrich, and J. A. Peterson, Oxygenated cytochrome P-450 and its possible role in enzymic hydroxylation, Biochem. Biophys. Res. Commun., 42, 140-146 (1971).
42. R. W. Estabrook, A. G. Hildebrandt, J. Baron, K. J. Netter, and K. Leibman, A new spectral intermediate associated with cytochrome P-450 function in liver microsomes, Biochem. Biophys. Res. Commun., 42, 132-139 (1971).
43. H. Yamazaki, W. W. Johnson, Y. F. Ueng, T. Shimada, and F. P. Guengerich, Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome b5 reductase system and studies with apo-cytochrome b5, J. Biol. Chem., 271, 27438-27444 (1996).
44. R. J. Auchus, T. C. Lee, and W. L. Miller, Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer, J. Biol. Chem., 273, 3158-3165 (1998).
45. R. W. Estabrook, M. R. Franklin, J. Baron, and A. G. Hildebrandt, Factors influencing the inhibitory effect of carbon monoxide on cytochrome P-450 catalyzed mixed function oxidation reactions, in Ann. NY Acad. Sci., 174, 218-232 (1970).
46. A. G. Hildebrandt, C. K. Leibman, and R. W. Estabrook, Metyrapone interactions with hepatic microsomal cytochrome P450 from rats treated with phenobarbital, Biochem. Biophys. Res. Commun., 37, 477-485 (1969).
47. A. G. Hildebrandt, The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed function oxidation reactions, in Symposium on Biological Hydroxylation Reactions, British Biochemical Society Symp. 34 (G. S. Boyd and R. M. S. Smellie, eds.), Academic Press, London, 1972.